Endo International plc Announces Proposed Exchange Offers And Consent Solicitations
- Thursday, May 14, 2020, 7:04
- Finance
- Add a comment
DUBLIN, May 14, 2020 /PRNewswire/ — Endo International plc (the “Company”) (NASDAQ:ENDP) announced today that its wholly owned subsidiaries, Par Pharmaceutical, Inc., a New York corporation (“PPI”), Endo Designated Activity Company, a designated activity company incorporated under the…
About the Author
adminasapcorp has written 41769 stories on this site.